Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129

Clarissa Pedrosa da Costa Gomes; Bence Agg; Andrejaana Andova; Serdal Arslan; Andrew Baker; Monika Bartekova; Dimitris Beis; Fay Betsou; Stephanie Bezzina Wettinger; Branko Bugarski; Gianluigi Condorelli; Gustavo Jose Justo da Silva; Sabrina Danilin; David de Gonzalo-Calvo; Alfonso Buil; Maria Carmo-Fonseca; Francisco J. Enguita; Kyriacos Felekkis; Peter Ferdinandy; Mariann Gyoengyoesi; Matthias Hackl; Kanita Karaduzovic-Hadziabdic; Jan Hellemans; Stephane Heymans; Marketa Hlavackova; Morten Andre Hoydal; Aleksandra Jankovic; Amela Jusic; Dimitris Kardassis; Risto Kerkela; Gabriela M. Kuster; Paivi Lakkisto; Przemyslaw Leszek; Mitja Lustrek; Lars Maegdefessel; Fabio Martelli; Susana Novella; Timothy O'Brien; Christos Papaneophytou; Thierry Pedrazzini; Florence Pinet; Octavian Popescu; Ines Potocnjak; Emma Robinson; Shlomo Sasson; Markus Scholz; Maya Simionescu; Monika Stoll; Zoltan V. Varga; Manlio Vinciguerra; EU-CardioRNA COST Action (CA17129); Yvan Devaux

doi:10.3390/ncrna5020031

Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129

Clarissa Pedrosa da Costa Gomes, Bence Agg, Andrejaana Andova, Serdal Arslan, Andrew Baker, Monika Bartekova, Dimitris Beis, Fay Betsou, Stephanie Bezzina Wettinger, Branko Bugarski, Gianluigi Condorelli, Gustavo Jose Justo da Silva, Sabrina Danilin, David de Gonzalo-Calvo, Alfonso Buil, Maria Carmo-Fonseca, Francisco J. Enguita, Kyriacos Felekkis, Peter Ferdinandy, Mariann GyoengyoesiMatthias Hackl, Kanita Karaduzovic-Hadziabdic, Jan Hellemans, Stephane Heymans, Marketa Hlavackova, Morten Andre Hoydal, Aleksandra Jankovic, Amela Jusic, Dimitris Kardassis, Risto Kerkela, Gabriela M. Kuster, Paivi Lakkisto, Przemyslaw Leszek, Mitja Lustrek, Lars Maegdefessel, Fabio Martelli, Susana Novella, Timothy O'Brien, Christos Papaneophytou, Thierry Pedrazzini, Florence Pinet, Octavian Popescu, Ines Potocnjak, Emma Robinson, Shlomo Sasson, Markus Scholz, Maya Simionescu, Monika Stoll, Zoltan V. Varga, Manlio Vinciguerra, EU-CardioRNA COST Action (CA17129), Yvan Devaux^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).

Original language	English
Article number	31
Number of pages	13
Journal	Non-coding RNA research
Volume	5
Issue number	2
DOIs	https://doi.org/10.3390/ncrna5020031
Publication status	Published - Jun 2019

Keywords

LONG NONCODING RNAS
CIRCULATING MICRORNAS
PERSPECTIVES
BIOMARKERS
TARGETS

Access to Document

10.3390/ncrna5020031Licence: CC BY

Cite this

Gomes, C. P. D. C., Agg, B., Andova, A., Arslan, S., Baker, A., Bartekova, M., Beis, D., Betsou, F., Wettinger, S. B., Bugarski, B., Condorelli, G., da Silva, G. J. J., Danilin, S., de Gonzalo-Calvo, D., Buil, A., Carmo-Fonseca, M., Enguita, F. J., Felekkis, K., Ferdinandy, P., ... Devaux, Y. (2019). Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. Non-coding RNA research, 5(2), Article 31. https://doi.org/10.3390/ncrna5020031

@article{de128be518c24843b38a48a291009781,

title = "Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129",

abstract = "Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).",

keywords = "LONG NONCODING RNAS, CIRCULATING MICRORNAS, PERSPECTIVES, BIOMARKERS, TARGETS",

author = "Gomes, {Clarissa Pedrosa da Costa} and Bence Agg and Andrejaana Andova and Serdal Arslan and Andrew Baker and Monika Bartekova and Dimitris Beis and Fay Betsou and Wettinger, {Stephanie Bezzina} and Branko Bugarski and Gianluigi Condorelli and {da Silva}, {Gustavo Jose Justo} and Sabrina Danilin and {de Gonzalo-Calvo}, David and Alfonso Buil and Maria Carmo-Fonseca and Enguita, {Francisco J.} and Kyriacos Felekkis and Peter Ferdinandy and Mariann Gyoengyoesi and Matthias Hackl and Kanita Karaduzovic-Hadziabdic and Jan Hellemans and Stephane Heymans and Marketa Hlavackova and Hoydal, {Morten Andre} and Aleksandra Jankovic and Amela Jusic and Dimitris Kardassis and Risto Kerkela and Kuster, {Gabriela M.} and Paivi Lakkisto and Przemyslaw Leszek and Mitja Lustrek and Lars Maegdefessel and Fabio Martelli and Susana Novella and Timothy O'Brien and Christos Papaneophytou and Thierry Pedrazzini and Florence Pinet and Octavian Popescu and Ines Potocnjak and Emma Robinson and Shlomo Sasson and Markus Scholz and Maya Simionescu and Monika Stoll and Varga, {Zoltan V.} and Manlio Vinciguerra and {EU-CardioRNA COST Action (CA17129)} and Yvan Devaux",

note = "Funding Information: Funding: This work is supported by COST (European Cooperation in Science and Technology) Action EU-CardioRNA CA17129. YD is the chair and CE is the vice-chair of the European COST Action CA17129, CardioRNA. Funding Information: This work is supported by COST (European Cooperation in Science and Technology) Action EU-CardioRNA CA17129. YD is the chair and CE is the vice-chair of the European COST Action CA17129, CardioRNA Publisher Copyright: {\textcopyright} 2018 by the authors.",

year = "2019",

month = jun,

doi = "10.3390/ncrna5020031",

language = "English",

volume = "5",

journal = "Non-coding RNA research",

issn = "2468-0540",

publisher = "KeAi Communications Co",

number = "2",

}

Gomes, CPDC, Agg, B, Andova, A, Arslan, S, Baker, A, Bartekova, M, Beis, D, Betsou, F, Wettinger, SB, Bugarski, B, Condorelli, G, da Silva, GJJ, Danilin, S, de Gonzalo-Calvo, D, Buil, A, Carmo-Fonseca, M, Enguita, FJ, Felekkis, K, Ferdinandy, P, Gyoengyoesi, M, Hackl, M, Karaduzovic-Hadziabdic, K, Hellemans, J, Heymans, S, Hlavackova, M, Hoydal, MA, Jankovic, A, Jusic, A, Kardassis, D, Kerkela, R, Kuster, GM, Lakkisto, P, Leszek, P, Lustrek, M, Maegdefessel, L, Martelli, F, Novella, S, O'Brien, T, Papaneophytou, C, Pedrazzini, T, Pinet, F, Popescu, O, Potocnjak, I, Robinson, E, Sasson, S, Scholz, M, Simionescu, M, Stoll, M, Varga, ZV, Vinciguerra, M, EU-CardioRNA COST Action (CA17129) & Devaux, Y 2019, 'Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129', Non-coding RNA research, vol. 5, no. 2, 31. https://doi.org/10.3390/ncrna5020031

TY - JOUR

T1 - Catalyzing Transcriptomics Research in Cardiovascular Disease

T2 - The CardioRNA COST Action CA17129

AU - Gomes, Clarissa Pedrosa da Costa

AU - Agg, Bence

AU - Andova, Andrejaana

AU - Arslan, Serdal

AU - Baker, Andrew

AU - Bartekova, Monika

AU - Beis, Dimitris

AU - Betsou, Fay

AU - Wettinger, Stephanie Bezzina

AU - Bugarski, Branko

AU - Condorelli, Gianluigi

AU - da Silva, Gustavo Jose Justo

AU - Danilin, Sabrina

AU - de Gonzalo-Calvo, David

AU - Buil, Alfonso

AU - Carmo-Fonseca, Maria

AU - Enguita, Francisco J.

AU - Felekkis, Kyriacos

AU - Ferdinandy, Peter

AU - Gyoengyoesi, Mariann

AU - Hackl, Matthias

AU - Karaduzovic-Hadziabdic, Kanita

AU - Hellemans, Jan

AU - Heymans, Stephane

AU - Hlavackova, Marketa

AU - Hoydal, Morten Andre

AU - Jankovic, Aleksandra

AU - Jusic, Amela

AU - Kardassis, Dimitris

AU - Kerkela, Risto

AU - Kuster, Gabriela M.

AU - Lakkisto, Paivi

AU - Leszek, Przemyslaw

AU - Lustrek, Mitja

AU - Maegdefessel, Lars

AU - Martelli, Fabio

AU - Novella, Susana

AU - O'Brien, Timothy

AU - Papaneophytou, Christos

AU - Pedrazzini, Thierry

AU - Pinet, Florence

AU - Popescu, Octavian

AU - Potocnjak, Ines

AU - Robinson, Emma

AU - Sasson, Shlomo

AU - Scholz, Markus

AU - Simionescu, Maya

AU - Stoll, Monika

AU - Varga, Zoltan V.

AU - Vinciguerra, Manlio

AU - EU-CardioRNA COST Action (CA17129)

AU - Devaux, Yvan

N1 - Funding Information: Funding: This work is supported by COST (European Cooperation in Science and Technology) Action EU-CardioRNA CA17129. YD is the chair and CE is the vice-chair of the European COST Action CA17129, CardioRNA. Funding Information: This work is supported by COST (European Cooperation in Science and Technology) Action EU-CardioRNA CA17129. YD is the chair and CE is the vice-chair of the European COST Action CA17129, CardioRNA Publisher Copyright: © 2018 by the authors.

PY - 2019/6

Y1 - 2019/6

N2 - Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).

AB - Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).

KW - LONG NONCODING RNAS

KW - CIRCULATING MICRORNAS

KW - PERSPECTIVES

KW - BIOMARKERS

KW - TARGETS

U2 - 10.3390/ncrna5020031

DO - 10.3390/ncrna5020031

M3 - Article

C2 - 30934986

SN - 2468-0540

VL - 5

JO - Non-coding RNA research

JF - Non-coding RNA research

IS - 2

M1 - 31

ER -

Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129

Abstract

Keywords

Access to Document

Fingerprint

Cite this